Cartilago Logo

About

Cartilago has developed a proprietary peptidyl derivative of glucosamine with proven enhanced chemical characteristics. 

Cartilago is developing a first-of-its-kind, disease-modifying proprietary osteoarthritis (OA) drug. It promotes cartilage tissue repair when administered into joints. In parallel, Cartilago is developing an anti-aging dermatological product that has already been tested in a PoC, inducing reduction of fine wrinkles in the periocular area. 

 

Cartilago

Founded

2017